George Miljanich
Fondatore presso SiteOne Therapeutics, Inc.
Profilo
George Miljanich is the founder and Chief Scientific Officer of SiteOne Therapeutics, Inc. which is founded in 2010.
He is currently the Chief Executive Officer at Airmid, Inc. Dr. Miljanich has an undergraduate degree from the University of California, Berkeley and a doctorate from the University of California, Santa Cruz.
Posizioni attive di George Miljanich
Società | Posizione | Inizio |
---|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Fondatore | 01/01/2010 |
Airmid, Inc.
Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Amministratore Delegato | - |
Formazione di George Miljanich
University of California, Berkeley | Undergraduate Degree |
University of California, Santa Cruz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
Airmid, Inc.
Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Health Technology |
- Borsa valori
- Insiders
- George Miljanich